Paper29686263
BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma.
Sime W and 10 others. Cell Death Dis, 2018. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma. Papers, record 29686263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29686263
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 14-3-3 Proteins | Major topic |
| Apoptosis | Major topic |
| Cell Cycle | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Neuroblastoma | Major topic |
| Tumor Suppressor Proteins | Major topic |
| Ubiquitin Thiolesterase | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Female | |
| Humans | |
| Mice | |
| Mice, Nude | |
| Proto-Oncogene Proteins c-bcl-2 | |
| bcl-2-Associated X Protein |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22367537 | Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. | Nature | 2012 | https://conductscience.org/library/papers/22367537 | PubMed |
| 2 | 20558371 | Recent advances in neuroblastoma. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20558371 | PubMed |
| 3 | 9528852 | BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. | Oncogene | 1998 | https://conductscience.org/library/papers/9528852 | PubMed |
| 4 | 21874000 | Germline BAP1 mutations predispose to malignant mesothelioma. | Nat Genet | 2011 | https://conductscience.org/library/papers/21874000 | PubMed |
| 5 | 29222693 | Neuroblastoma pathogenesis: deregulation of embryonic neural crest development. | Cell Tissue Res | 2018 | https://conductscience.org/library/papers/29222693 | PubMed |
| 6 | 23442169 | Copynumber: Efficient algorithms for single- and multi-track copy number segmentation. | BMC Genomics | 2012 | https://conductscience.org/library/papers/23442169 | PubMed |
| 7 | 24909169 | Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells. | Oncogene | 2015 | https://conductscience.org/library/papers/24909169 | PubMed |
| 8 | 18757409 | BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. | Cancer Res | 2008 | https://conductscience.org/library/papers/18757409 | PubMed |
| 9 | 10913676 | Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization. | Cancer Genet Cytogenet | 2000 | https://conductscience.org/library/papers/10913676 | PubMed |
| 10 | 15890640 | Targeting apoptosis pathways in cancer therapy. | CA Cancer J Clin | 2005 | https://conductscience.org/library/papers/15890640 | PubMed |
| 11 | 10936180 | Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. | J Neurochem | 2000 | https://conductscience.org/library/papers/10936180 | PubMed |
| 12 | 19117993 | BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity. | Cancer Res | 2009 | https://conductscience.org/library/papers/19117993 | PubMed |
| 13 | 20805357 | The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression. | Mol Cell Biol | 2010 | https://conductscience.org/library/papers/20805357 | PubMed |
| 14 | 21051595 | Frequent mutation of BAP1 in metastasizing uveal melanomas. | Science | 2010 | https://conductscience.org/library/papers/21051595 | PubMed |
| 15 | 22878500 | Loss of the tumor suppressor BAP1 causes myeloid transformation. | Science | 2012 | https://conductscience.org/library/papers/22878500 | PubMed |
| 16 | 22366560 | Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth. | Eur J Cancer | 2012 | https://conductscience.org/library/papers/22366560 | PubMed |
| 17 | 25228651 | Deubiquitination of γ-tubulin by BAP1 prevents chromosome instability in breast cancer cells. | Cancer Res | 2014 | https://conductscience.org/library/papers/25228651 | PubMed |
| 18 | 22802690 | An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma. | Int J Nanomedicine | 2012 | https://conductscience.org/library/papers/22802690 | PubMed |
| 19 | 11533726 | Re-evaluating centrosome function. | Nat Rev Mol Cell Biol | 2001 | https://conductscience.org/library/papers/11533726 | PubMed |
| 20 | 23277170 | Tumours associated with BAP1 mutations. | Pathology | 2013 | https://conductscience.org/library/papers/23277170 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42499709 | Tumor suppressor BAP1 emerges as a key regulator of metabolism and cell death in tumors. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42499709 | PubMed |
| 42287015 | The Importance of 14-3-3 Proteins in Colorectal Cancer Regulation: Mechanisms of Function and Clinical Opportunities. | Biomed Res Int | 2026 | https://conductscience.org/library/papers/42287015 | PubMed |
| 42168844 | REDD1 deficiency alleviates podocyte PANoptosis and restores autophagy in diabetic kidney disease. | Mol Med | 2026 | https://conductscience.org/library/papers/42168844 | PubMed |
| 41744857 | Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: Efficacy, Real-World Outcomes, and the Search for Predictive Biomarkers. | Curr Oncol | 2026 | https://conductscience.org/library/papers/41744857 | PubMed |
| 41718807 | BRCA1-Associated Protein 1 (BAP1) in Human Cancer and its Emerging Role as a Novel Potential Therapeutic Target. | Curr Oncol Rep | 2026 | https://conductscience.org/library/papers/41718807 | PubMed |
| 39842618 | An overview of BAP1 biological functions and current therapeutics. | Biochim Biophys Acta Rev Cancer | 2025 | https://conductscience.org/library/papers/39842618 | PubMed |
| 39709491 | TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosis. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/39709491 | PubMed |
| 39266549 | Tumor suppressor BAP1 suppresses disulfidptosis through the regulation of SLC7A11 and NADPH levels. | Oncogenesis | 2024 | https://conductscience.org/library/papers/39266549 | PubMed |
| 39119237 | YWHAB is regulated by IRX5 and inhibits the migration and invasion of breast cancer cells. | Oncol Lett | 2024 | https://conductscience.org/library/papers/39119237 | PubMed |
| 39005671 | Potential roles of UCH family deubiquitinases in tumorigenesis and chemical inhibitors developed against them. | Am J Cancer Res | 2024 | https://conductscience.org/library/papers/39005671 | PubMed |
| 37543638 | Deficiency of BAP1 inhibits neuroblastoma tumorigenesis through destabilization of MYCN. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/37543638 | PubMed |
| 37009801 | BAP1 as a guardian of genome stability: implications in human cancer. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/37009801 | PubMed |
| 36253570 | PBRM1, SETD2 and BAP1 - the trinity of 3p in clear cell renal cell carcinoma. | Nat Rev Urol | 2023 | https://conductscience.org/library/papers/36253570 | PubMed |
| 35637285 | BAP1 promotes the repair of UV-induced DNA damage via PARP1-mediated recruitment to damage sites and control of activity and stability. | Cell Death Differ | 2022 | https://conductscience.org/library/papers/35637285 | PubMed |
| 35584569 | BAP1 phosphorylation-mediated Sp1 stabilization plays a critical role in cathepsin K inhibition-induced C-terminal p53-dependent Bax upregulation. | Redox Biol | 2022 | https://conductscience.org/library/papers/35584569 | PubMed |
| 35446349 | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | J Cell Biol | 2022 | https://conductscience.org/library/papers/35446349 | PubMed |
| 34733850 | Immune Signatures Combined With BRCA1-Associated Protein 1 Mutations Predict Prognosis and Immunotherapy Efficacy in Clear Cell Renal Cell Carcinoma. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34733850 | PubMed |
| 34622229 | Molecular predictors of response to pembrolizumab in thymic carcinoma. | Cell Rep Med | 2021 | https://conductscience.org/library/papers/34622229 | PubMed |
| 33919439 | Deubiquitinases: Modulators of Different Types of Regulated Cell Death. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33919439 | PubMed |
| 33833407 | Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis. | Acta Pharmacol Sin | 2022 | https://conductscience.org/library/papers/33833407 | PubMed |
Genes45
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29686263
GET https://conductscience.org/api/papers/v1/29686263/references?page=2